A Synthetic Peptide, CK2.3, Inhibits RANKL-Induced Osteoclastogenesis through BMPRIa and ERK Signaling Pathway
The skeletal system plays an important role in the development and maturation process. Through the bone remodeling process, 10% of the skeletal system is renewed every year. Osteoblasts and osteoclasts are two major bone cells that are involved in the development of the skeletal system, and their ac...
Main Authors: | John Nguyen, Semaj Kelly, Ryan Wood, Brian Heubel, Anja Nohe |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Journal of Developmental Biology |
Subjects: | |
Online Access: | https://www.mdpi.com/2221-3759/8/3/12 |
Similar Items
-
Aberrant BMP2 Signaling in Patients Diagnosed with Osteoporosis
by: Hilary W. Durbano, et al.
Published: (2020-09-01) -
A Novel Peptide, CK2.3, Improved Bone Formation in Ovariectomized Sprague Dawley Rats
by: Linda Sequeira, et al.
Published: (2020-07-01) -
Bone Morphogenetic Protein-2 in Development and Bone Homeostasis
by: Daniel Halloran, et al.
Published: (2020-09-01) -
Mechanisms of Cellular Internalization of Quantum Dot® Conjugated Bone Formation Mimetic Peptide CK2.3
by: Vrathasha Vrathasha, et al.
Published: (2018-07-01) -
Synergy effects of Asperosaponin VI and bioactive factor BMP-2 on osteogenesis and anti-osteoclastogenesis
by: Fangping Chen, et al.
Published: (2022-04-01)